Amount Raised
$54 Million
Round Type
Series C
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharmaDescription
OnKure, Inc. a precision oncology company, today announced that it has successfully closed a $54 million Series C financing. The financing was led by Surveyor Capital (a Citadel company) with participation from new investor Deep Track Capital, as well as existing investors Acorn Bioventures, Cormorant Asset Management, Perceptive Advisors, Samsara BioCapital, funds and accounts managed by BlackRock, and other undisclosed investors.
Quick answer
OnKure Therapeutics raised $54 Million in a Series C round, dated May 23, 2023. OnKure Therapeutics is based in Boulder, Colorado, United States.
- How much did OnKure Therapeutics raise?
- OnKure Therapeutics raised $54 Million in a Series C round on May 23, 2023.
- What does OnKure Therapeutics do?
- OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated..
- Where is OnKure Therapeutics based and how big is it?
- OnKure Therapeutics is based in Boulder, Colorado, United States. Fundz records about 40 employees.
- Who are the decision-makers at OnKure Therapeutics?
- Fundz holds 1 contact at OnKure Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as OnKure Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Foresee Pharmaceuticals raised $42M (Funding Round) on June 27, 2023.
- Entero Therapeutics raised $431K (Seed) on June 13, 2023.
- Alkeus Pharmaceuticals raised $150M (Series B) on June 5, 2023.
- Azora Therapeutics, Inc. (DE) raised $53K (Pre-Seed) on May 31, 2023.
- Renibus Therapeutics raised $64M on May 25, 2023.
- Biodexa Pharmaceuticals raised $3.3M (Seed) on May 23, 2023.
Who to call at OnKure Therapeutics, and when
A new round usually means OnKure Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OnKure Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OnKure Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OnKure Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OnKure Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.